3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
59
Neoplasm Metastasis
5
Prostate Cancer Metastatic
3
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
3
Adenocarcinoma
3
Prostate CA
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Metastatic Hormone-sensitive Prostate Cancer
2
Metastatic Castration-resistant Prostate Cancer
2
Urologic Diseases
1
Urogenital Neoplasms
1
Triple Negative Breast Neoplasms
1
Stage IV Prostate Adenocarcinoma AJCC v7
1
Salivary Gland Neoplasms
1
Recurrence
1
Radiation Injuries
1
Prostatic Diseases
1
PSA Level Greater Than 0.03
1
Oligometastatic Prostate Cancer
1
Neoplasms
1
Neoplasm Recurrence, Local
1
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
1
Metastatic Hormone-Sensitive Prostate Cance
1
Metastatic Hormone Sensitive Prostate Cancer
1
Metastatic Castrate-sensitive Prostate Cancer
1
Lymphatic Metastasis
1
Intraprostatic Prostate Cancer
1
Hormone Sensitive Prostate Cancer
1
Genital Neoplasms, Male
1
Gastrointestinal Diseases
1
Interventions
Radiotherapy
3
Radiation
3
Magnetic Resonance Spectroscopy
3
relugolix
2
luprolide acetate gel depot
2
enzalutamide
2
bicalutamide
2
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
2
Specimen Handling
2
Radiosurgery
2
Leuprolide
2
Goserelin
2
Biopsy
2
radium Ra 223 dichloride
1
niraparib
1
histrelin
1
gallium 68 PSMA-11
1
darolutamide
1
abiraterone
1
X-Rays
1
Triptorelin Pamoate
1
Surgical Procedures, Operative
1
Salicylic Acid
1
Radium-223
1
Radiotherapy, Image-Guided
1
Radiation Dose Hypofractionation
1
Proton Therapy
1
Prednisone
1
Lymph Node Excision
1
Glutamate Carboxypeptidase II
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Prostate Adenocarcinoma
×
Androgen Antagonists
×
1 year
×
Clear all
No trials found.